Margin call! Regulators should increase burden of OTC trades
IOSCO and the Basel Committee have proposed collateral-tasty requirements for non-centrally cleared derivatives trades. They are hopeful regulators across the globe will adopt the same standards to reduce regulatory arbitrage.
New proposals outlining how companies need to provide collateral for over-the-non-centrally cleared counter derivatives trades have been published. For corporations not used to supplying collateral, the implications could be huge.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to CorporateTreasurer.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a treasurer, CFO or senior professional at a corporate or SME, please register for free VIP access here.
Questions?
See here for more information on licences and prices, or contact [email protected].
© Haymarket Media Limited. All rights reserved.
Top news, insights and analysis every Tuesday & Thursday
Free registration gives you access to our email newsletters
for unlimited access to all articles, newsletters
Related Articles
Zee Germans are coming!
Dec 17, 2012
Europe pushes back Basel III
Dec 3, 2012
Why Asia benefits from new OTC carve outs
Sep 16, 2013